Introduction
============

Activation of a growing number of oncogenes has been found associated with "replication stress," a poorly understood perturbation of DNA replication ([@bib25]; [@bib2], [@bib3]; [@bib17]; [@bib12]; [@bib14]). Replication stress induces the activation of the DNA damage response (DDR), which is detected from the earliest stages of tumorigenesis ([@bib1]). Oncogene-induced replication stress is associated with the formation of double-strand breaks (DSBs), particularly in regions intrinsically difficult to replicate ([@bib2], [@bib3]; [@bib17]). The observed DDR activation induces senescence in precancerous lesions and functions as a barrier against full malignant transformation ([@bib3]; [@bib12]).

Oncogene activation affects---directly or via deregulation of CDK2---the replication initiation program, resulting in deregulated origin firing and impaired fork progression. The latter effect is proposed to result from nucleotide depletion ([@bib7]), from interference between DNA replication and transcription ([@bib23]), and/or from increased DNA torsional stress ([@bib6]), but the lack of structural information on replication intermediates (RIs) under these experimental conditions has so far limited our understanding of the underlying mechanisms. Furthermore, it is unclear how perturbations at the replication forks lead to DSB formation that promotes chromosomal rearrangements during tumorigenesis.

Replication stress has been recently associated with transient accumulation of DNA lesions and large 53BP1 foci formed when cells progress through mitosis ([@bib24]). It was previously reported that different oncogenes lead to mitotic aberrations ([@bib28]; [@bib21]), but the causative link between these phenotypes and oncogene-induced genotoxic stress has remained obscure. Recently, additional molecular events of potential importance for chromosomal integrity were associated with mitotic entry, e.g., the resolution of Holliday junctions (HJs), central intermediates of DNA homologous recombination (HR; [@bib26]; [@bib34]). Furthermore, the HJ resolvase MUS81 was recently implicated in DSB formation upon oncogene overexpression (OE) or cell cycle perturbation, but the link to mitotic progression is controversial and the underlying mechanisms remained elusive ([@bib4]; [@bib13]; [@bib15]; [@bib29]).

In this work, comparing OE of *Cyclin E* (*CycE*) and *Cdc25A*, we identify reversed forks as common unusual replication intermediates, suggesting increased topological stress as a critical determinant of oncogene-induced replication stress. Surprisingly, fork slowing and restructuring are, per se, neither associated with chromosomal breakage nor with full DDR activation. We show that processing of these unusual replication intermediates by MUS81 depends on mitotic entry and contributes to oncogene-induced DSBs. Premature CDK1 activation upon checkpoint inactivation accelerates and exacerbates oncogene-induced DSB formation, providing a mechanistic rationale for the function of the DNA damage checkpoints as barriers against genome instability. Thus, specific DNA structures and cell cycle transitions mediate oncogene-induced chromosomal breakage.

Results and discussion
======================

Oncogene OE rapidly interferes with replication fork progression and induces fork reversal
------------------------------------------------------------------------------------------

To elucidate the impact of oncogenes on the replication process, we focused on two established systems of oncogene OE ([@bib25]; [@bib2]) as prototypes of two different scenarios: (1) "Oncogene OE only" by *CycE* OE, where CDK2 hyperactivation deregulates DNA replication; and (2) "Oncogene OE + checkpoint defect" by *Cdc25A* OE. As this phosphatase is at the same time a CDK activator and a key effector of the DNA damage response ([@bib25]), *Cdc25A* OE combines CDK2 deregulation with impaired cell cycle control, two key steps in tumorigenesis ([@bib3]; [@bib12]).

We tested the effect of both oncogenes on the progression of individual replication forks by DNA fiber spreading analysis ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib22]). In keeping with two recent reports ([@bib7]; [@bib23]), oncogene OE is associated with a significant replication fork slowdown. We now show that this fork delay does not require prolonged oncogene expression ([@bib7]), but is detectable in both systems from the earliest time point (8 h; [Fig. 1, A--C](#fig1){ref-type="fig"}). Next, we investigated in vivo replication fork architecture upon oncogene OE by electron microscopy (EM; [@bib31]). Our most striking observation was the accumulation of reversed forks (RFs), i.e., replication forks showing a fourth regressed arm, due to local annealing of the newly synthesized strands ([Fig. 1, D and E](#fig1){ref-type="fig"}). Although these are rare intermediates during unperturbed S phase, they rapidly accumulate upon OE of both *CycE* and *Cdc25A* ([Fig. 1, D--G](#fig1){ref-type="fig"}; and [Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp1}). Furthermore, their frequency does not further increase at later time points ([Fig. 1, F and G](#fig1){ref-type="fig"}). Upon OE of both oncogenes, we also detected an increasing number of molecules exposing extended single-stranded DNA (ssDNA) regions, mainly as gaps on newly synthesized strands, but also at the replication fork (Fig. S1, B--F). In *Cdc25A*-overexpressing cells, a few replication bubbles showed one side entirely single stranded (hemireplicated bubble; Fig. S1 C; [@bib35]). Moreover, in a subset of RIs from later time points of *CycE* OE, we occasionally detected ssDNA gaps on the parental strands (Fig. S1 D), suggesting that ssDNA regions are carried over from the previous round of replication. To exclude that our results are specific for cancer cells, we transiently overexpressed both oncogenes in untransformed human MRC5 fibroblasts. Transient *CycE* and *Cdc25A* OE in MRC5 resulted in replication fork slowdown similar to that in U2OS cells, and was accompanied by the accumulation of RF- and ssDNA-containing molecules ([Fig. S2, A--D](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp2}). Overall, these data identify common features of DNA replication stress---i.e., fork slowing, fork reversal, and ssDNA accumulation---detectable with similar kinetics upon OE of both oncogenes, and provide direct evidence that oncogene OE affects the structure of replication intermediates in vivo.

![**Oncogene OE slows down replication forks and induces fork reversal.** (A) DNA tracts pulse-labeled with CldU and IdU from control cells (0 h) and cells overexpressing the indicated oncogene for 8 h. (B and C) Analysis of replication fork progression by DNA fiber spreading before (0 h) and after induction of *CycE*, and *Cdc25A*, respectively. Bottom panels show oncogene OE. (D and E) Electron micrographs of reversed forks from cells overexpressing *CycE* and *Cdc25A*, respectively. Insets show magnified forks and schemes of fork structure. Black and gray lines describe parental and newly synthesized DNA strands, respectively. (F and G) Frequency of reversed replication forks after induction of *CycE* and *Cdc25A*, respectively. "\# RI" is the number of analyzed replication intermediates. Panels on the right show oncogene OE. Data in F and G were reproduced in at least one independent experiment. At least 100 tracts were scored per sample in B and C. Whiskers: 10--90th percentile (\*\*\*, P \< 0.0001; ns, not significant, Mann-Whitney test). Bars: (A) 5 µm; (D and E) 200 nm (500 bp); (insets) 50 nm. TFIIH as loading control. Molecular weight in kD of nearest protein size marker is indicated.](JCB_201212058_Fig1){#fig1}

Cell cycle progression, chromosomal breakage, and DDR upon *CycE* and *Cdc25A* OE
---------------------------------------------------------------------------------

We next tested whether replication stress is associated with DSBs, cell cycle arrest, and DDR activation. *CycE* OE leads to transient accumulation of cells in S and G2/M phases, followed at late time points (4--8 d) by accumulation of rereplicating cells (DNA content \>4n; [Fig. 2 A](#fig2){ref-type="fig"}). Cell cycle deregulation by *CycE* OE delayed proliferation only three days after oncogene induction ([Fig. 2 B](#fig2){ref-type="fig"}). Mild ATR/CHK1 activation was detectable within 24 h of *CycE* OE, whereas DNA breakage---as assessed by pulse-field gel electrophoresis (PFGE) ---and ATM/KAP1 phosphorylation were detected only after 4--8 d ([Fig. 2, C and D](#fig2){ref-type="fig"}), when the cells accumulate in G2/M and occasionally rereplicate ([Fig. 2 A](#fig2){ref-type="fig"}). Thus, in this experimental system, oncogene-induced fork slowing and reversal precede and are not directly associated with DSBs ([Fig. 1, F and G](#fig1){ref-type="fig"}; and [Fig. 2](#fig2){ref-type="fig"}). In contrast, *Cdc25A* OE leads to a marked arrest of cell cycle and proliferation already one day after induction ([Fig. 2, E and F](#fig2){ref-type="fig"}). ATR/CHK1 activation was detectable early after oncogene OE (8 h) and was rapidly associated with massive DNA breakage (16--24 h) and ATM/KAP1 activation ([Fig. 2, G and H](#fig2){ref-type="fig"}).

![**Oncogene OE deregulates the cell cycle and causes DNA breakage and bi-phasic DDR activation.** (A and E) FACS analysis of DNA content (DAPI) of cells overexpressing *CycE* for up to 8 d and *Cdc25A* for up to 72 h, respectively. For additional data on the accumulation of cells with \>4n DNA, see [Figs. 3 B](#fig3){ref-type="fig"} and [S3 H](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp3}. Data are from a single representative experiment out of four repeats. (B and F) Proliferation of cells overexpressing *CycE* and *Cdc25A*, respectively (mean + SEM, *n* = 4). (C and G) DNA breakage after *CycE* and *Cdc25A* OE monitored by pulse-field gel electrophoresis. (D and H) DDR activation (pCHK1, pKAP1) and total DDR proteins (CHK1, KAP1) upon OE of *CycE* and *Cdc25A*, respectively. TFIIH serves as loading control for D and the top panels of H; total KAP1 levels control for KAP1 pS284 in the bottom panels of H. Molecular weight in kD of nearest protein size marker is indicated.](JCB_201212058_Fig2){#fig2}

Transient OE of *CycE* and *Cdc25*A in MRC5 yielded similar results, in that *CycE* OE for 48 h neither caused DSB nor DDR activation, whereas *Cdc25A* OE resulted in DSB formation and stepwise activation of ATR/CHK1 and ATM/KAP1 (Fig. S2, E and F). Overall, CDK2 deregulation by both *CycE* and *Cdc25A* OE rapidly induces prolonged S phase and ATR activation, and accumulation of unusual replication intermediates. However, chromosomal breakage and cell cycle arrest occur with strikingly different kinetics in the two systems.

Marked replication stress does not activate the DDR until cells experience a persistent G2/M arrest (*CycE*) or a premature replication block (*Cdc25A*)
--------------------------------------------------------------------------------------------------------------------------------------------------------

To further characterize oncogene-induced DNA breakage and DDR, we studied H2AX phosphorylation (γ-H2AX) and 53BP1 recruitment by single-cell immunofluorescence (IF). Whereas the former event marks sites of DNA damage in general, the latter is more specific for DSBs ([@bib11]; [@bib33]). Despite the marked replication phenotypes ([Figs. 1](#fig1){ref-type="fig"} and S2), *CycE*-overexpressing cells showed no γ-H2AX above background for 2--3 d after induction. 10--20% of the cells did show γ-H2AX foci at later time points (4--8 d), when DSBs become physically detectable ([Figs. 2 C](#fig2){ref-type="fig"}, [3 A](#fig3){ref-type="fig"}, and [S3 A](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp4}). Coupling IF-based γ-H2AX detection with flow-cytometric analysis of DNA content (DAPI) and replication (5-ethynyl-2′-deoxyuridine \[EdU\]; Fig. S3, B and C), we observed that increased γ-H2AX levels upon prolonged *CycE* OE are mainly present in cells accumulating in G2/M or attempting rereplication ([Fig. 3 B](#fig3){ref-type="fig"}). Rereplicating cells were also easily identified by IF microscopy because of their "giant nuclei" ([@bib40]) and displayed accumulation of γ-H2AX foci, mostly colocalizing with 53BP1, thus marking DSBs (Fig. S3 D). In contrast, the DDR observed upon *Cdc25A* OE was more rapid and heterogeneous. Cells with γ-H2AX/53BP1 foci were detected 8 h after *Cdc25A* induction, whereas after 24 h a significant fraction of cells showed intense pan-nuclear γ-H2AX ([Fig. 3, C and D](#fig3){ref-type="fig"}), a phenotype previously associated with replication stress ([@bib30]). Pan-nuclear γ-H2AX was consistently associated with intermediate DNA content and compromised EdU incorporation, suggesting a replicative arrest ([Fig. 3 E](#fig3){ref-type="fig"}). These cells also consistently show intense DAPI staining and, in spite of the high γ-H2AX signal, are devoid of 53BP1 foci ([Fig. 3 C](#fig3){ref-type="fig"}). Both features are characteristic of mitotic chromatin condensation ([@bib16]). *Cdc25A* OE also rapidly induced an increase in nuclear fragmentation, frequently associated with pan-nuclear γ-H2AX ([Fig. 3 C](#fig3){ref-type="fig"}; Fig. S3, E and F). A similar phenotype was associated with prolonged *CycE* OE (Fig. S2 G). In summary, *CycE*-overexpressing cells show mild and slow accumulation of DSB markers in IF and FACS. In contrast, these markers are rapidly detectable upon *Cdc25A* OE and correlate with mitotic features in cells experiencing a replicative arrest.

![**Different kinetics, extent, and cell cycle dependency of DDR activation upon *Cdc25A* and *CycE* OE.** (A) γ-H2AX--positive cells (green) before (0 h) and at the indicated time points after *CycE* induction quantified by single-cell IF (see also [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp5}). (B) FACS analysis of DNA synthesis (EdU), DNA content (DAPI), and DDR activation (γ-H2AX) in cells overexpressing *CycE*. γ-H2AX--positive cells (foci) in green. (C) Single-cell IF of control cells (0 h) and cells overexpressing *Cdc25A* for 8 h and 24 h stained for γ-H2AX and 53BP1. Green arrowhead, cell with γ-H2AX foci. Red arrowhead, cell with pan-nuclear γ-H2AX. (D) γ-H2AX--positive cells quantified by single-cell IF, and (E) FACS analysis of cells overexpressing *Cdc25A*. Cells with γ-H2AX foci in green and pan-nuclear γ-H2AX in red. (A and D) mean + SEM, *n* = 4. Bar, 10 µm. For OE data on *CycE* and *Cdc25A*, see [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp6}. Data in B and E are from a single representative experiment out of four repeats.](JCB_201212058_Fig3){#fig3}

Massive chromosomal breakage and DDR are associated with premature activation of mitotic markers and suppressed by CDK1 inhibition
----------------------------------------------------------------------------------------------------------------------------------

The results shown so far imply that oncogene-induced replication stress does not directly lead to DSB formation. However, they suggest that oncogene-induced DSBs occur either in mitosis or upon premature mitotic entry. To test this hypothesis, we used a broad-spectrum marker of mitotic CDK1-activity---the MPM-2 antibody, which recognizes an abundant phospho-epitope on CDK1 substrates ([@bib9])---and found that 24 h after *Cdc25A* induction this marker is no longer restricted to mitotic cells, but detectable also in a substantial fraction of cells with intermediate DNA content ([Fig. 4, A and B](#fig4){ref-type="fig"}). Furthermore, intense γ-H2AX in *Cdc25A*-overexpressing cells is associated with elevated levels of MPM-2 ([Fig. 4 A](#fig4){ref-type="fig"}), establishing a link between premature mitotic entry and oncogene-induced DDR activation. To assess directly whether initiation of mitosis is required for *Cdc25A*-induced DNA breakage, we overexpressed the oncogene in the presence of the CDK1 inhibitor RO-3306 ([@bib39]). CDK1 inhibition did not interfere with oncogene expression, allowed transit into S phase, and did not affect the initial (8 h) increase of CHK1 activity induced by *Cdc25A* OE ([Figs. 4 C](#fig4){ref-type="fig"} and S3 I). However, *Cdc25A*-induced DSB and ATM activation were completely suppressed ([Fig. 4, C--E](#fig4){ref-type="fig"}). Accordingly, CHK1 phosphorylation after 12--16 h, presumably resulting from DSB resection, was also suppressed ([Fig. 4 C](#fig4){ref-type="fig"}). In checkpoint-proficient cells, the ATR pathway restricts CDK1 activity in response to replication stress. To test whether ATR limits oncogene-induced DNA breakage, we inhibited ATR in *CycE*-overexpressing cells ([@bib37]). Indeed, ATR inhibition increased the amount of *CycE*-induced DSBs after prolonged *CycE* OE (Fig. S3, J--L). Taken together, our data indicate that the massive chromosomal breakage induced by *Cdc25A* OE is associated with and depends on premature initiation of mitosis.

![**Cdc25A-induced DSBs depend on CDK1-mediated mitotic entry and on MUS81-dependent processing of reversed forks.** (A) FACS analysis for phosphorylation of CDK1 substrates (MPM-2) and DDR activation (γ-H2AX) of control cells (0 h) and cells overexpressing *Cdc25A* for 24 h. High levels of γ-H2AX in unperturbed mitotic cells have been previously reported ([@bib27]). Data are from a single representative experiment out of three repeats. (B) *Cdc25A* OE in samples in A. (C) Activation of the DDR (pCHK1, pKAP1) and total DDR proteins (CHK1, KAP1) upon *Cdc25A* OE of *Cdc25A* in the absence or presence of the CDK1 inhibitor. S phase scored by EdU incorporation. (D) *Cdc25A*-induced DNA breakage assessed by PFGE, in the absence or presence of the CDK1 inhibitor. (E) *Cdc25A* OE in samples in D. (F) Immunoblot showing OE of *Cdc25A* and depletion of MUS81. S phase scored by EdU incorporation. (G) DNA breakage monitored by pulse-field gel electrophoresis before (0 h) and 24 h after induction of *Cdc25A* in mock- or MUS81-depleted cells. (H) Quantification of chromosomal breakage by PFGE in cells treated as in (F), mean + s.e.m., *n* ≥ 3, \* = P \< 0.05, Paired student's *t* test. (I) Frequency of reversed replication forks in cells treated as in F. "\# RI" is the number of analyzed replication intermediates. (J) Micrograph of a reversed replication fork from MUS81-depleted cells overexpressing *Cdc25A*. The regressed arm is connected to one of the daughter strands, leaving a gap at the branch point. Data in I was reproduced in one independent experiment. Bar: (main panel) 200 nm (500 bp); (inset) 50 nm. TFIIH as loading control. Molecular weight in kD of nearest protein size marker is indicated. For FACS profiles quantified in C and F, see [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201212058/DC1){#supp7}.](JCB_201212058_Fig4){#fig4}

Reversed forks are MUS81 substrates and precursors of oncogene-induced DSBs
---------------------------------------------------------------------------

The HJ resolvase MUS81-EME1 was previously suggested to process replication forks after prolonged arrest ([@bib18], [@bib19]), and was also recently implicated in oncogene-induced genotoxicity ([@bib29]), but neither its mechanistic role nor its substrates have been identified. We found that siRNA-mediated MUS81 depletion suppressed up to 60% of *Cdc25A*-induced breaks ([Fig. 4, F--H](#fig4){ref-type="fig"}; and Fig. S3 M). As we identified RFs as an abundant unusual intermediate upon oncogene OE, we tested the hypothesis that they are substrates for cleavage by MUS81. Indeed, MUS81 depletion caused an increase in *Cdc25A*-induced RFs, strictly correlating with the amount of residual protein and the decrease of DSBs ([Fig. 4, F--I](#fig4){ref-type="fig"}). A reproducible increase in RF frequency was also observed in the absence of oncogene OE, suggesting that occasional RFs formed in unperturbed conditions are targeted by MUS81. Overall these data show that RFs are substrates for MUS81 cleavage and precursors of oncogene-induced DNA breakage.

Our work sheds light on several important mechanistic aspects of oncogene-induced genotoxicity. We present the first direct visualization of the impact of oncogene OE on the structure of RIs in vivo. Although the observed accumulation of ssDNA was predicted by previous studies ([@bib2]), it is surprising that replication forks challenged by OE of both *CycE* and *Cdc25A* regress rapidly and frequently. Reversed forks were first shown in bacteria in response to torsional stress ([@bib32]). They had been long postulated also in eukaryotic cells ([@bib20]) and were shown to arise in yeast upon topological impediments induced by checkpoint defects ([@bib35]; [@bib5]). Most recently, reversed forks have been reported as frequent RI upon topoisomerase I poisoning also in higher eukaryotes ([@bib33]). Overall, the available data establish fork reversal as an evolutionary conserved response to topological constraints. Our structural observations support a scenario where oncogene OE impairs the replication process by inducing topological stress resulting from deregulating simultaneously CDK2-dependent origin firing and transcription ([Fig. 5](#fig5){ref-type="fig"}; [@bib6]). In line with this notion, most oncogenes shown to induce replication stress deregulate the G1--S transition ([@bib2], [@bib3]; [@bib12]). Accordingly, *CycE*-induced fork slowing was recently linked to high levels of replication initiation and the resulting interference between replication and transcription ([@bib23]). Prolonged exposure to oncogenic stress was also recently linked to nucleotide depletion ([@bib7]), which may arise as a consequence of supernumerary replication factories and contribute to replication fork stalling.

![**Replication stress and DNA damage induction upon *CycE* and *Cdc25A* OE.** (A) As many other oncogenes (e.g., *Cdc25A*), *CycE* OE causes CDK2 hyperactivation, deregulating the replication program and leading to topological stress. This impairs fork progression and promotes fork reversal. In the following G2/M, residual replication intermediates can be resolved into transient DNA lesions ([@bib24]), which are repaired in G1. Accumulation of replication stress upon prolonged oncogene OE leads to persistent G2/M arrest, mitotic defects (micronuclei), and rereplication associated with low DSB levels. (B) When CDK2 deregulation is associated with DNA damage checkpoint defects, as upon *Cdc25A* OE or in later stages of tumorigenesis, cells are no longer able to delay CDK1 activation. Premature CDK1 activation leads to mitotic aberrations (micronuclei) and to massive DNA breakage due to MUS81-mediated processing of reversed forks. Physiological and oncogene-induced pathological events are indicated in green and red, respectively. Further details are discussed in the text.](JCB_201212058_Fig5){#fig5}

A second unexpected conclusion of our work is that the manifestations of oncogene-induced replication stress (fork reversal and ssDNA exposure) are not, per se, leading to chromosomal breakage, but are tolerated without potent DDR activation for at least three cell cycles upon *CycE* OE. In contrast, *Cdc25A*-overexpressing cells show massive DNA breakage, pan-nuclear γ-H2AX, and cell cycle arrest already 16--24 h after induction. Our data identify the critical determinant of this difference in the regulation of CDK1-dependent mitotic entry, which is maintained upon oncogene OE (*CycE* OE), but lost with severe cellular consequences upon inactivation of cell cycle checkpoints (*Cdc25A* OE), often associated with malignant transformation. We propose that the replication stress observed early after oncogene induction is tolerated in *CycE*-overexpressing cells by means of controlled processing of replication intermediates during a transient, checkpoint-mediated delay in G2/M ([@bib24]). This transient arrest limits DNA breakage, as ATR inhibition under these conditions leads to an increase in *CycE*-induced DSBs (Fig. S3, J--L). However, the accumulation of "DNA lesions" upon prolonged *CycE* OE ([Figs. 1](#fig1){ref-type="fig"} and S1) may eventually lead to a persistent G2/M arrest, extensive processing of replication intermediates, inaccurate chromosome segregation (e.g., micronuclei; Fig. S3 G), and abortive attempts to restart DNA replication ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib12]; [@bib10]; [@bib8]). In contrast, *Cdc25A*-overexpressing cells---prototypic of checkpoint-deficient cells experiencing oncogenic stress---display constitutive CDK1 hyperactivation and are therefore unable to restrain mitotic processing, which is initiated together with the earliest manifestations of replication stress. Thus, they rapidly incur extensive DNA breakage, strong DDR activation, and replicative arrest. We propose that the crucial role of the DDR as an anticancer barrier results from its molecular function in the tolerance of oncogene-induced replication stress, by ensuring controlled processing of unusual RI and thus preventing excessive chromosomal breakage.

Finally, our work provides important mechanistic insight in the cellular activities involved in oncogene-induced chromosomal breakage. Combining PFGE and EM analysis, we show that MUS81/EME1---a cell cycle--regulated HJ resolvase ([@bib26])---is a major contributor to *Cdc25A*-induced DSBs by processing reversed forks ([Fig. 5 B](#fig5){ref-type="fig"}). These data demonstrate that HJs at replication forks are in vivo substrates of this nuclease, despite the weak cleavage activity in vitro ([@bib36]). Interestingly, at least a fraction of reversed forks displays ss-nicks or gaps at the branch point ([Figs. 4 J](#fig4){ref-type="fig"} and S1 A), which are known to enhance susceptibility to cleavage by MUS81 ([@bib34]). Furthermore, the observation that MUS81 controls the abundance of reversed forks also in unperturbed conditions suggests that these structures are formed even in the absence of exogenous stress and that their controlled processing is required for genome maintenance in every cell cycle.

Materials and methods
=====================

Cell culture, treatments, and transfections
-------------------------------------------

U2OS-derived clones carrying inducible copies of *CycE* and *Cdc25A* were grown in DMEM + 10% FCS supplemented with 4 µg/ml tetracycline. Oncogene expression was induced by washing off tetracycline. MRC5 cells were grown in DMEM + 10% FCS. For inhibition of CDK1, RO-3306 (\#217699; EMD Millipore) was added 3 h after oncogene induction at a final concentration of 9 µM. Tetracycline was from Sigma-Aldrich (T7660). For inhibition of ATR, the ATR inhibitor ETP-46464 (kindly provided by O. Fernandez-Capetillo, CNIO, Madrid, Spain) was added for 12 h before collection at a final concentration of 2 µM. For oncogene OE in MRC5 cells, cells were transfected with pBabe (empty vector), or plasmid encoding Cdc25A or CycE (kindly provided by J. Lukas, Center for Protein Research, Copenhagen, Denmark), respectively, at the indicated time points before collection using FuGENE6 (Promega) according to the manufacturer's instructions. For depletion experiments, cells were transfected 72 h before oncogene induction with the indicated siRNA using RNAiMax (Invitrogen) according to the manufacturer's instructions. siLUC (33 nM; 5′-GGUACGCGGAAUACUUCGAdTdT-3′), siMUS81\#1 (33 nM; 5′-CAGCCCUGGUGGAUCGAUAdTdT-3′), and siMUS81\#2 (80 nM; 5′-CAGGAGCCAUCAAGAAUAAdTdT-3′).

Flow cytometry
--------------

Cell cycle analysis by propidium iodide staining was performed as described previously ([@bib38]). In brief, cells were fixed with ice-cold 70% ethanol, washed with PBS, pH 7.4, and DNA was stained with 25 µg/ml propidium iodide (Sigma-Aldrich). For flow cytometric analysis for γ-H2AX/EdU/DAPI, cells were labeled for 30 min with 10 µM EdU, harvested, and fixed for 10 min with 4% formaldehyde/PBS. Cells were washed with 1% BSA/PBS, pH 7.4, permeabilized with 0.5% saponin/1% BSA/PBS, and stained with anti--γ-H2AX antibody (\#05-636; EMD Millipore) for 2 h, followed by incubation with a suitable secondary antibody for 30 min. Incorporated EdU was labeled according to the manufacturer's instructions (\#C35002; Invitrogen). For flow cytometric analysis for γ-H2AX/MPM-2/DAPI, cells were fixed and permeabilized as described above, followed by incubation with antibodies against γ-H2AX (\#9718; Cell Signaling Technology) and MPM-2 (\#05-368; EMD Millipore) and suitable secondary antibodies. In both assays, DNA was stained with 1 µg/ml DAPI. Samples were measured on a Cyan ADP flow cytometer (Beckman Coulter) and analyzed with Summit software v4.3 (Beckman Coulter).

Pulse-field gel electrophoresis, single-cell microscopy, and antibodies
-----------------------------------------------------------------------

Pulse-field gel electrophoresis was performed as reported previously ([@bib38]). In brief, cells were embedded in a 0.8% agarose plug (2.5 × 10^5^ cells/plug), digested in lysis buffer (100 mM EDTA, 1% \[wt/vol\] sodium lauryl sarcosyne, 0.2% \[wt/vol\] sodium deoxycholate, and 1 mg/ml proteinase K) at 37°C for 48 h, and washed in 10 mM Tris-HCl, pH 8.0, and 100 mM EDTA. Electrophoresis was performed at 14°C in 0.9% (wt/vol) Pulsed Field Certified Agarose (Bio-Rad Laboratories) containing Tris-borate/EDTA buffer in a CHEF DR III apparatus (9 h, 120°, 5.5 V/cm, 30--18 s switch time; 6 h, 117°, 4.5 V/cm, 18--9 s switch time; 6 h, 112°, 4 V/cm, 9--5 s switch time; Bio-Rad Laboratories). The gel was stained with ethidium bromide and imaged on an Alpha Innotech Imager. For single-cell immunostaining, cells were fixed with 4% formaldehyde/PBS, stained for γ-H2AX and 53BP1 as indicated, detected by appropriate secondary antibodies, and mounted with Vectashield (Vector Laboratories). Cells were imaged using a microscope (model DMRB; Leica) equipped with a camera (model DFC360 FX; Leica). Images were taken at 60×, using Leica Application Suite 3.3.0. The following primary antibodies were used: γ-H2AX (\#05-636; EMD Millipore), 53BP1 (sc-22760; Santa Cruz Biotechnology, Inc.), CycE (sc-198; Santa Cruz Biotechnology, Inc.), Cdc25A (sc-7389; Santa Cruz Biotechnology, Inc.), CHK1 pS345 (\#2348; Cell Signaling Technology), CHK1 (sc-8408; Santa Cruz Biotechnology, Inc.), KAP1-pS824 (A300-767A; Bethyl Laboratories, Inc.), KAP1 (A300-274A; Bethyl Laboratories, Inc.), TFIIH (sc-293; Santa Cruz Biotechnology, Inc.), MUS81 (M1445; Sigma-Aldrich), and β-tubulin (sc-5274; Santa Cruz Biotechnology, Inc.). Secondary antibodies were Alexa Fluor conjugates (Alexa Fluor 488, 594, and 647; Invitrogen).

DNA fiber spreadings
--------------------

Cells were sequentially pulse-labeled with 30 µM IdU and 250 µM CldU for 20 min each and harvested. Cells were then lysed and DNA fibers stretched onto glass slides, as described previously ([@bib33]). In brief, the fibers were denatured with 2.5 M HCl for 1 h, washed with PBS, and blocked with 0.2% Tween 20 in 2% BSA/PBS. CldU and IdU tracks were revealed with anti-BrdU antibodies recognizing CldU (ab6326; Abcam) and IdU (347580; BD), respectively, and appropriate secondary antibodies. Images were acquired with a microscope (model IX81; Olympus), CellR software (Olympus), and an Orca camera (Hamamatsu Photonics). Statistical analysis was performed using Prism (GraphPad Software).

Electron microscopic analysis of genomic DNA
--------------------------------------------

In vivo psoralen cross-linking, isolation of total genomic DNA, and enrichment of the replication intermediates and their EM visualization were performed as described previously ([@bib33]; [@bib31]). In brief, cells were harvested, and genomic DNA was cross-linked by two rounds of incubation in 10 µM 4,5′,8-trimethylpsoralen and 2 min of irradiation with 366-nm UV light. Cells were lysed, and genomic DNA was isolated from the nuclei by proteinase K digestion and phenol-chloroform extraction. Purified DNA was digested with PvuII and replication intermediates were enriched on a BND cellulose column. EM samples were prepared by spreading the DNA on carbon-coated grids and visualized by platinum rotary shadowing. Images were acquired on a microscope (G2 Spirit; FEI Tecnai) and analyzed with ImageJ (National Institutes of Health). Statistical analysis was performed using Prism.

Online supplemental material
----------------------------

Fig. S1 shows reversed replication forks and replication intermediates with exposed ssDNA observed upon OE of *Cdc25A* and *CycE*, and statistics on the accumulation of ssDNA regions under these conditions. Fig. S2 shows replication fork slow-down, accumulation of unusual replication intermediates, DSB formation, and DDR activation upon OE of *Cdc25A* and *CycE* in MRC5 cells. Fig. S3 illustrates the different H2AX phosphorylation patterns detected upon oncogene OE in FACS and single-cell IF, shows IF data on DDR markers (γ-H2AX and 53BP1), and accumulation of micronuclei and cells with ≥4n DNA in oncogene-overexpressing cells, FACS profiles for samples in [Fig. 4](#fig4){ref-type="fig"}, and the effect of ATR inhibition on *CycE*-overexpressing cells. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201212058/DC1>.
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